Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Immunocore Ltd
Sponsor:
Information provided by (Responsible Party):
Immunocore Ltd
ClinicalTrials.gov Identifier:
NCT01211262
First received: September 28, 2010
Last updated: August 14, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)